Variable | All patients (n = 415) | Living donor recipient (n = 97) | Deceased donor recipient (n = 318) | p-value^ |
---|---|---|---|---|
Age, years | 49.8 (38.9–59.6) | 40.0 (30.7–53.3) | 51.2 (41.5–62.4) | < 0.001 |
Male, n (%) | 244 (59) | 51 (53) | 174 (61) | 0.155 |
Caucasian, n (%) | 352 (88) | 97 (100) | 311 (98) | 0.141 |
Hypertension, n (%) | 383 (92) | 90 (93) | 293 (92) | 0.835 |
Diabetes mellitus, n (%) | 48 (12) | 6 (6) | 42 (13) | 0.058 |
Primary renal disease | ||||
Glomerulonephritis, n (%) | 120 (29) | 35 (36) | 85 (27) | 0.075 |
ADPKD, n (%) | 55 (13) | 14 (14) | 41 (13) | 0.695 |
Diabetic nephropathy, n (%) | 44 (11) | 6 (6) | 38 (12) | 0.106 |
Hypertensive nephropathy, n (%) | 21 (5) | 5 (5) | 16 (5) | 0.961 |
Laboratory values | ||||
*eGFR, ml/min/1.73m2 | 54.1 (41.6–70.5) | 58 (46–75) | 53 (40–70) | 0.114 |
eGFR< 45 ml/min/1.73m2, n (%) | 125 (30) | 24 (25) | 104 (33) | 0.137 |
†uACR, mg/g | 22.1 (11.5–65.4) | 23.9 (12.4–68.1) | 21.2 (12.4–64.5) | 0.473 |
‡Calcium, mg/dL | 9.44 (9.1–9.9) | 9.40 (9.08–9.80) | 9.48 (9.12–9.96) | 0.151 |
‡Phosphate, mg/dL | 2.88 (2.43–3.31) | 2.88 (2.45–3.38) | 2.85 (2.42–3.31) | 0.917 |
Bicarbonate, mEq/L | 22.8 (21.2–25.0) | 22.6 (21.3–23.8) | 23.0 (21.2–25.4) | 0.185 |
¶Albumin, g/dL | 4.4 (4.2–4.6) | 4.5 (4.4–4.7) | 4.4 (4.2–4.6) | 0.004 |
Outcome | ||||
Graft failure within 5 years, n (%) | 16 (4) | 6 (6) | 10 (3) | 0.173 |
Time to graft failure, years | 3.51 (2.87–4.19) | 3.14 (2.86–3.94) | 3.62 (3.02–4.14) | 0.588 |